A multicentre phase II trial of gemcitabine and oxaliplatin (GEMOX) in patients with biliary tract cancer.

Trial Profile

A multicentre phase II trial of gemcitabine and oxaliplatin (GEMOX) in patients with biliary tract cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Feb 2012

At a glance

  • Drugs Gemcitabine; Oxaliplatin
  • Indications Biliary cancer
  • Focus Therapeutic Use
  • Acronyms EXIBIT
  • Most Recent Events

    • 01 Sep 2008 Results published in the British Journal of Cancer.
    • 27 Jan 2007 Status changed from in progress to completed
    • 18 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top